nodes	percent_of_prediction	percent_of_DWPC	metapath
Decitabine—Nucleic Acid Synthesis Inhibitors—Fluorouracil—skin cancer	0.877	1	CiPCiCtD
Decitabine—DNMT3A—connective tissue—skin cancer	0.00211	0.0922	CbGeAlD
Decitabine—DNMT3A—skin of body—skin cancer	0.0019	0.0832	CbGeAlD
Decitabine—DNMT1—nipple—skin cancer	0.0018	0.0786	CbGeAlD
Decitabine—DNMT3A—lymphoid tissue—skin cancer	0.00154	0.0674	CbGeAlD
Decitabine—DNMT3A—female reproductive system—skin cancer	0.00149	0.065	CbGeAlD
Decitabine—DNMT1—connective tissue—skin cancer	0.00127	0.0558	CbGeAlD
Decitabine—DCK—nipple—skin cancer	0.00124	0.0544	CbGeAlD
Decitabine—DNMT3A—head—skin cancer	0.00124	0.0543	CbGeAlD
Decitabine—DNMT1—epithelium—skin cancer	0.00121	0.0529	CbGeAlD
Decitabine—DNMT1—skin of body—skin cancer	0.00115	0.0503	CbGeAlD
Decitabine—DNMT1—mammalian vulva—skin cancer	0.00105	0.0459	CbGeAlD
Decitabine—DNMT1—lymphoid tissue—skin cancer	0.000932	0.0408	CbGeAlD
Decitabine—DNMT1—female reproductive system—skin cancer	0.000899	0.0393	CbGeAlD
Decitabine—DNMT3A—lymph node—skin cancer	0.00087	0.038	CbGeAlD
Decitabine—DNMT1—head—skin cancer	0.000751	0.0329	CbGeAlD
Decitabine—DCK—mammalian vulva—skin cancer	0.000726	0.0318	CbGeAlD
Decitabine—DCK—lymphoid tissue—skin cancer	0.000645	0.0282	CbGeAlD
Decitabine—DCK—female reproductive system—skin cancer	0.000622	0.0272	CbGeAlD
Decitabine—DNMT1—lymph node—skin cancer	0.000526	0.023	CbGeAlD
Decitabine—DCK—head—skin cancer	0.00052	0.0227	CbGeAlD
Decitabine—DCK—lymph node—skin cancer	0.000364	0.0159	CbGeAlD
Decitabine—Erythema—Dactinomycin—skin cancer	0.000118	0.00117	CcSEcCtD
Decitabine—Pain in extremity—Docetaxel—skin cancer	0.000118	0.00117	CcSEcCtD
Decitabine—Ill-defined disorder—Bleomycin—skin cancer	0.000117	0.00117	CcSEcCtD
Decitabine—Anaemia—Bleomycin—skin cancer	0.000117	0.00116	CcSEcCtD
Decitabine—Diarrhoea—Vemurafenib—skin cancer	0.000117	0.00116	CcSEcCtD
Decitabine—Urticaria—Imiquimod—skin cancer	0.000115	0.00115	CcSEcCtD
Decitabine—Body temperature increased—Imiquimod—skin cancer	0.000115	0.00114	CcSEcCtD
Decitabine—Abdominal pain—Imiquimod—skin cancer	0.000115	0.00114	CcSEcCtD
Decitabine—Eye disorder—Temozolomide—skin cancer	0.000115	0.00114	CcSEcCtD
Decitabine—Malaise—Bleomycin—skin cancer	0.000114	0.00114	CcSEcCtD
Decitabine—Cardiac disorder—Temozolomide—skin cancer	0.000114	0.00113	CcSEcCtD
Decitabine—Haemoglobin—Fluorouracil—skin cancer	0.000114	0.00113	CcSEcCtD
Decitabine—Leukopenia—Bleomycin—skin cancer	0.000113	0.00113	CcSEcCtD
Decitabine—Haemorrhage—Fluorouracil—skin cancer	0.000113	0.00112	CcSEcCtD
Decitabine—Dizziness—Vemurafenib—skin cancer	0.000113	0.00112	CcSEcCtD
Decitabine—Hypoaesthesia—Fluorouracil—skin cancer	0.000112	0.00112	CcSEcCtD
Decitabine—Pharyngitis—Fluorouracil—skin cancer	0.000112	0.00112	CcSEcCtD
Decitabine—Angiopathy—Temozolomide—skin cancer	0.000111	0.00111	CcSEcCtD
Decitabine—Immune system disorder—Temozolomide—skin cancer	0.000111	0.0011	CcSEcCtD
Decitabine—Mediastinal disorder—Temozolomide—skin cancer	0.00011	0.0011	CcSEcCtD
Decitabine—Cough—Bleomycin—skin cancer	0.00011	0.0011	CcSEcCtD
Decitabine—Chills—Temozolomide—skin cancer	0.00011	0.00109	CcSEcCtD
Decitabine—Dehydration—Docetaxel—skin cancer	0.00011	0.00109	CcSEcCtD
Decitabine—Ill-defined disorder—Dactinomycin—skin cancer	0.000109	0.00109	CcSEcCtD
Decitabine—Anaemia—Dactinomycin—skin cancer	0.000109	0.00109	CcSEcCtD
Decitabine—Liver function test abnormal—Docetaxel—skin cancer	0.000109	0.00108	CcSEcCtD
Decitabine—Vomiting—Vemurafenib—skin cancer	0.000108	0.00108	CcSEcCtD
Decitabine—Alopecia—Temozolomide—skin cancer	0.000108	0.00108	CcSEcCtD
Decitabine—Dry skin—Docetaxel—skin cancer	0.000108	0.00107	CcSEcCtD
Decitabine—Chest pain—Bleomycin—skin cancer	0.000108	0.00107	CcSEcCtD
Decitabine—Myalgia—Bleomycin—skin cancer	0.000108	0.00107	CcSEcCtD
Decitabine—Abdominal pain upper—Docetaxel—skin cancer	0.000108	0.00107	CcSEcCtD
Decitabine—Rash—Vemurafenib—skin cancer	0.000107	0.00107	CcSEcCtD
Decitabine—Mental disorder—Temozolomide—skin cancer	0.000107	0.00107	CcSEcCtD
Decitabine—Dermatitis—Vemurafenib—skin cancer	0.000107	0.00107	CcSEcCtD
Decitabine—Hypersensitivity—Imiquimod—skin cancer	0.000107	0.00107	CcSEcCtD
Decitabine—Headache—Vemurafenib—skin cancer	0.000107	0.00106	CcSEcCtD
Decitabine—Erythema—Temozolomide—skin cancer	0.000107	0.00106	CcSEcCtD
Decitabine—Malnutrition—Temozolomide—skin cancer	0.000107	0.00106	CcSEcCtD
Decitabine—Discomfort—Bleomycin—skin cancer	0.000106	0.00106	CcSEcCtD
Decitabine—Malaise—Dactinomycin—skin cancer	0.000106	0.00106	CcSEcCtD
Decitabine—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000106	0.00106	CcSEcCtD
Decitabine—Leukopenia—Dactinomycin—skin cancer	0.000106	0.00105	CcSEcCtD
Decitabine—Nasopharyngitis—Docetaxel—skin cancer	0.000105	0.00105	CcSEcCtD
Decitabine—Asthenia—Imiquimod—skin cancer	0.000104	0.00104	CcSEcCtD
Decitabine—Confusional state—Bleomycin—skin cancer	0.000104	0.00104	CcSEcCtD
Decitabine—Anaphylactic shock—Bleomycin—skin cancer	0.000103	0.00103	CcSEcCtD
Decitabine—Oedema—Bleomycin—skin cancer	0.000103	0.00103	CcSEcCtD
Decitabine—Back pain—Temozolomide—skin cancer	0.000103	0.00103	CcSEcCtD
Decitabine—Pruritus—Imiquimod—skin cancer	0.000103	0.00102	CcSEcCtD
Decitabine—Infection—Bleomycin—skin cancer	0.000103	0.00102	CcSEcCtD
Decitabine—Dysphagia—Docetaxel—skin cancer	0.000102	0.00101	CcSEcCtD
Decitabine—Nausea—Vemurafenib—skin cancer	0.000101	0.00101	CcSEcCtD
Decitabine—Thrombocytopenia—Bleomycin—skin cancer	0.000101	0.00101	CcSEcCtD
Decitabine—Vision blurred—Temozolomide—skin cancer	0.000101	0.001	CcSEcCtD
Decitabine—Myalgia—Dactinomycin—skin cancer	0.0001	0.001	CcSEcCtD
Decitabine—Alopecia—Fluorouracil—skin cancer	9.98e-05	0.000993	CcSEcCtD
Decitabine—Diarrhoea—Imiquimod—skin cancer	9.94e-05	0.000989	CcSEcCtD
Decitabine—Discomfort—Dactinomycin—skin cancer	9.93e-05	0.000988	CcSEcCtD
Decitabine—Ill-defined disorder—Temozolomide—skin cancer	9.9e-05	0.000985	CcSEcCtD
Decitabine—Anaemia—Temozolomide—skin cancer	9.86e-05	0.000981	CcSEcCtD
Decitabine—Anorexia—Bleomycin—skin cancer	9.84e-05	0.000979	CcSEcCtD
Decitabine—Erythema—Fluorouracil—skin cancer	9.83e-05	0.000978	CcSEcCtD
Decitabine—Pancytopenia—Docetaxel—skin cancer	9.67e-05	0.000962	CcSEcCtD
Decitabine—Hypotension—Bleomycin—skin cancer	9.65e-05	0.00096	CcSEcCtD
Decitabine—Oedema—Dactinomycin—skin cancer	9.63e-05	0.000958	CcSEcCtD
Decitabine—Malaise—Temozolomide—skin cancer	9.62e-05	0.000958	CcSEcCtD
Decitabine—Dizziness—Imiquimod—skin cancer	9.61e-05	0.000956	CcSEcCtD
Decitabine—Infection—Dactinomycin—skin cancer	9.57e-05	0.000952	CcSEcCtD
Decitabine—Leukopenia—Temozolomide—skin cancer	9.55e-05	0.00095	CcSEcCtD
Decitabine—Neutropenia—Docetaxel—skin cancer	9.52e-05	0.000948	CcSEcCtD
Decitabine—Thrombocytopenia—Dactinomycin—skin cancer	9.43e-05	0.000938	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Bleomycin—skin cancer	9.41e-05	0.000936	CcSEcCtD
Decitabine—Cough—Temozolomide—skin cancer	9.31e-05	0.000927	CcSEcCtD
Decitabine—Vision blurred—Fluorouracil—skin cancer	9.27e-05	0.000922	CcSEcCtD
Decitabine—Vomiting—Imiquimod—skin cancer	9.24e-05	0.000919	CcSEcCtD
Decitabine—Weight decreased—Docetaxel—skin cancer	9.22e-05	0.000917	CcSEcCtD
Decitabine—Hypertension—Temozolomide—skin cancer	9.21e-05	0.000917	CcSEcCtD
Decitabine—Dyspnoea—Bleomycin—skin cancer	9.21e-05	0.000916	CcSEcCtD
Decitabine—Anorexia—Dactinomycin—skin cancer	9.18e-05	0.000913	CcSEcCtD
Decitabine—Rash—Imiquimod—skin cancer	9.16e-05	0.000912	CcSEcCtD
Decitabine—Dermatitis—Imiquimod—skin cancer	9.16e-05	0.000911	CcSEcCtD
Decitabine—Pneumonia—Docetaxel—skin cancer	9.13e-05	0.000909	CcSEcCtD
Decitabine—Headache—Imiquimod—skin cancer	9.11e-05	0.000906	CcSEcCtD
Decitabine—Anaemia—Fluorouracil—skin cancer	9.09e-05	0.000904	CcSEcCtD
Decitabine—Myalgia—Temozolomide—skin cancer	9.09e-05	0.000904	CcSEcCtD
Decitabine—Arthralgia—Temozolomide—skin cancer	9.09e-05	0.000904	CcSEcCtD
Decitabine—Infestation—Docetaxel—skin cancer	9.08e-05	0.000904	CcSEcCtD
Decitabine—Infestation NOS—Docetaxel—skin cancer	9.08e-05	0.000904	CcSEcCtD
Decitabine—Anxiety—Temozolomide—skin cancer	9.05e-05	0.000901	CcSEcCtD
Decitabine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	9.02e-05	0.000898	CcSEcCtD
Decitabine—Discomfort—Temozolomide—skin cancer	8.98e-05	0.000893	CcSEcCtD
Decitabine—Decreased appetite—Bleomycin—skin cancer	8.98e-05	0.000893	CcSEcCtD
Decitabine—Acute coronary syndrome—Docetaxel—skin cancer	8.95e-05	0.000891	CcSEcCtD
Decitabine—Renal failure—Docetaxel—skin cancer	8.93e-05	0.000888	CcSEcCtD
Decitabine—Myocardial infarction—Docetaxel—skin cancer	8.9e-05	0.000886	CcSEcCtD
Decitabine—Stomatitis—Docetaxel—skin cancer	8.85e-05	0.000881	CcSEcCtD
Decitabine—Pain—Bleomycin—skin cancer	8.83e-05	0.000879	CcSEcCtD
Decitabine—Leukopenia—Fluorouracil—skin cancer	8.8e-05	0.000876	CcSEcCtD
Decitabine—Confusional state—Temozolomide—skin cancer	8.78e-05	0.000874	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Dactinomycin—skin cancer	8.77e-05	0.000873	CcSEcCtD
Decitabine—Anaphylactic shock—Temozolomide—skin cancer	8.71e-05	0.000867	CcSEcCtD
Decitabine—Oedema—Temozolomide—skin cancer	8.71e-05	0.000867	CcSEcCtD
Decitabine—Infection—Temozolomide—skin cancer	8.65e-05	0.000861	CcSEcCtD
Decitabine—Nausea—Imiquimod—skin cancer	8.63e-05	0.000859	CcSEcCtD
Decitabine—Hepatobiliary disease—Docetaxel—skin cancer	8.59e-05	0.000855	CcSEcCtD
Decitabine—Epistaxis—Docetaxel—skin cancer	8.57e-05	0.000852	CcSEcCtD
Decitabine—Nervous system disorder—Temozolomide—skin cancer	8.54e-05	0.00085	CcSEcCtD
Decitabine—Thrombocytopenia—Temozolomide—skin cancer	8.53e-05	0.000849	CcSEcCtD
Decitabine—Feeling abnormal—Bleomycin—skin cancer	8.51e-05	0.000847	CcSEcCtD
Decitabine—Skin disorder—Temozolomide—skin cancer	8.46e-05	0.000842	CcSEcCtD
Decitabine—Chest pain—Fluorouracil—skin cancer	8.37e-05	0.000833	CcSEcCtD
Decitabine—Myalgia—Fluorouracil—skin cancer	8.37e-05	0.000833	CcSEcCtD
Decitabine—Decreased appetite—Dactinomycin—skin cancer	8.37e-05	0.000833	CcSEcCtD
Decitabine—Fatigue—Dactinomycin—skin cancer	8.3e-05	0.000826	CcSEcCtD
Decitabine—Anorexia—Temozolomide—skin cancer	8.3e-05	0.000826	CcSEcCtD
Decitabine—Discomfort—Fluorouracil—skin cancer	8.27e-05	0.000823	CcSEcCtD
Decitabine—Pain—Dactinomycin—skin cancer	8.24e-05	0.000819	CcSEcCtD
Decitabine—Urticaria—Bleomycin—skin cancer	8.2e-05	0.000816	CcSEcCtD
Decitabine—Haemoglobin—Docetaxel—skin cancer	8.19e-05	0.000815	CcSEcCtD
Decitabine—Body temperature increased—Bleomycin—skin cancer	8.16e-05	0.000812	CcSEcCtD
Decitabine—Haemorrhage—Docetaxel—skin cancer	8.15e-05	0.000811	CcSEcCtD
Decitabine—Hypoaesthesia—Docetaxel—skin cancer	8.11e-05	0.000807	CcSEcCtD
Decitabine—Confusional state—Fluorouracil—skin cancer	8.09e-05	0.000805	CcSEcCtD
Decitabine—Pharyngitis—Docetaxel—skin cancer	8.09e-05	0.000805	CcSEcCtD
Decitabine—Urinary tract disorder—Docetaxel—skin cancer	8.05e-05	0.000801	CcSEcCtD
Decitabine—Oedema peripheral—Docetaxel—skin cancer	8.03e-05	0.000799	CcSEcCtD
Decitabine—Oedema—Fluorouracil—skin cancer	8.03e-05	0.000798	CcSEcCtD
Decitabine—Anaphylactic shock—Fluorouracil—skin cancer	8.03e-05	0.000798	CcSEcCtD
Decitabine—Connective tissue disorder—Docetaxel—skin cancer	8.01e-05	0.000797	CcSEcCtD
Decitabine—Urethral disorder—Docetaxel—skin cancer	7.99e-05	0.000795	CcSEcCtD
Decitabine—Infection—Fluorouracil—skin cancer	7.97e-05	0.000793	CcSEcCtD
Decitabine—Feeling abnormal—Dactinomycin—skin cancer	7.94e-05	0.00079	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Temozolomide—skin cancer	7.94e-05	0.00079	CcSEcCtD
Decitabine—Insomnia—Temozolomide—skin cancer	7.88e-05	0.000784	CcSEcCtD
Decitabine—Gastrointestinal pain—Dactinomycin—skin cancer	7.87e-05	0.000784	CcSEcCtD
Decitabine—Nervous system disorder—Fluorouracil—skin cancer	7.87e-05	0.000783	CcSEcCtD
Decitabine—Thrombocytopenia—Fluorouracil—skin cancer	7.86e-05	0.000782	CcSEcCtD
Decitabine—Tachycardia—Fluorouracil—skin cancer	7.83e-05	0.000779	CcSEcCtD
Decitabine—Dyspnoea—Temozolomide—skin cancer	7.77e-05	0.000773	CcSEcCtD
Decitabine—Dyspepsia—Temozolomide—skin cancer	7.67e-05	0.000763	CcSEcCtD
Decitabine—Anorexia—Fluorouracil—skin cancer	7.65e-05	0.000761	CcSEcCtD
Decitabine—Eye disorder—Docetaxel—skin cancer	7.62e-05	0.000758	CcSEcCtD
Decitabine—Body temperature increased—Dactinomycin—skin cancer	7.61e-05	0.000757	CcSEcCtD
Decitabine—Abdominal pain—Dactinomycin—skin cancer	7.61e-05	0.000757	CcSEcCtD
Decitabine—Hypersensitivity—Bleomycin—skin cancer	7.61e-05	0.000757	CcSEcCtD
Decitabine—Decreased appetite—Temozolomide—skin cancer	7.57e-05	0.000753	CcSEcCtD
Decitabine—Cardiac disorder—Docetaxel—skin cancer	7.57e-05	0.000753	CcSEcCtD
Decitabine—Gastrointestinal disorder—Temozolomide—skin cancer	7.52e-05	0.000748	CcSEcCtD
Decitabine—Fatigue—Temozolomide—skin cancer	7.51e-05	0.000747	CcSEcCtD
Decitabine—Hypotension—Fluorouracil—skin cancer	7.5e-05	0.000746	CcSEcCtD
Decitabine—Pain—Temozolomide—skin cancer	7.45e-05	0.000741	CcSEcCtD
Decitabine—Constipation—Temozolomide—skin cancer	7.45e-05	0.000741	CcSEcCtD
Decitabine—Asthenia—Bleomycin—skin cancer	7.41e-05	0.000737	CcSEcCtD
Decitabine—Angiopathy—Docetaxel—skin cancer	7.4e-05	0.000736	CcSEcCtD
Decitabine—Immune system disorder—Docetaxel—skin cancer	7.36e-05	0.000733	CcSEcCtD
Decitabine—Mediastinal disorder—Docetaxel—skin cancer	7.35e-05	0.000731	CcSEcCtD
Decitabine—Chills—Docetaxel—skin cancer	7.32e-05	0.000728	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Fluorouracil—skin cancer	7.31e-05	0.000727	CcSEcCtD
Decitabine—Pruritus—Bleomycin—skin cancer	7.31e-05	0.000727	CcSEcCtD
Decitabine—Insomnia—Fluorouracil—skin cancer	7.26e-05	0.000722	CcSEcCtD
Decitabine—Alopecia—Docetaxel—skin cancer	7.2e-05	0.000717	CcSEcCtD
Decitabine—Feeling abnormal—Temozolomide—skin cancer	7.18e-05	0.000714	CcSEcCtD
Decitabine—Dyspnoea—Fluorouracil—skin cancer	7.15e-05	0.000712	CcSEcCtD
Decitabine—Mental disorder—Docetaxel—skin cancer	7.14e-05	0.000711	CcSEcCtD
Decitabine—Gastrointestinal pain—Temozolomide—skin cancer	7.12e-05	0.000709	CcSEcCtD
Decitabine—Erythema—Docetaxel—skin cancer	7.1e-05	0.000706	CcSEcCtD
Decitabine—Malnutrition—Docetaxel—skin cancer	7.1e-05	0.000706	CcSEcCtD
Decitabine—Hypersensitivity—Dactinomycin—skin cancer	7.1e-05	0.000706	CcSEcCtD
Decitabine—Dyspepsia—Fluorouracil—skin cancer	7.06e-05	0.000703	CcSEcCtD
Decitabine—Decreased appetite—Fluorouracil—skin cancer	6.98e-05	0.000694	CcSEcCtD
Decitabine—Gastrointestinal disorder—Fluorouracil—skin cancer	6.93e-05	0.000689	CcSEcCtD
Decitabine—Urticaria—Temozolomide—skin cancer	6.92e-05	0.000688	CcSEcCtD
Decitabine—Asthenia—Dactinomycin—skin cancer	6.91e-05	0.000687	CcSEcCtD
Decitabine—Abdominal pain—Temozolomide—skin cancer	6.89e-05	0.000685	CcSEcCtD
Decitabine—Body temperature increased—Temozolomide—skin cancer	6.89e-05	0.000685	CcSEcCtD
Decitabine—Back pain—Docetaxel—skin cancer	6.87e-05	0.000683	CcSEcCtD
Decitabine—Pain—Fluorouracil—skin cancer	6.86e-05	0.000683	CcSEcCtD
Decitabine—Muscle spasms—Docetaxel—skin cancer	6.82e-05	0.000679	CcSEcCtD
Decitabine—Feeling abnormal—Fluorouracil—skin cancer	6.61e-05	0.000658	CcSEcCtD
Decitabine—Diarrhoea—Dactinomycin—skin cancer	6.59e-05	0.000656	CcSEcCtD
Decitabine—Vomiting—Bleomycin—skin cancer	6.57e-05	0.000653	CcSEcCtD
Decitabine—Anaemia—Docetaxel—skin cancer	6.56e-05	0.000653	CcSEcCtD
Decitabine—Rash—Bleomycin—skin cancer	6.51e-05	0.000648	CcSEcCtD
Decitabine—Dermatitis—Bleomycin—skin cancer	6.5e-05	0.000647	CcSEcCtD
Decitabine—Hypersensitivity—Temozolomide—skin cancer	6.42e-05	0.000638	CcSEcCtD
Decitabine—Urticaria—Fluorouracil—skin cancer	6.38e-05	0.000634	CcSEcCtD
Decitabine—Leukopenia—Docetaxel—skin cancer	6.35e-05	0.000632	CcSEcCtD
Decitabine—Body temperature increased—Fluorouracil—skin cancer	6.34e-05	0.000631	CcSEcCtD
Decitabine—Asthenia—Temozolomide—skin cancer	6.25e-05	0.000622	CcSEcCtD
Decitabine—Cough—Docetaxel—skin cancer	6.19e-05	0.000616	CcSEcCtD
Decitabine—Pruritus—Temozolomide—skin cancer	6.16e-05	0.000613	CcSEcCtD
Decitabine—Nausea—Bleomycin—skin cancer	6.13e-05	0.00061	CcSEcCtD
Decitabine—Hypertension—Docetaxel—skin cancer	6.13e-05	0.00061	CcSEcCtD
Decitabine—Vomiting—Dactinomycin—skin cancer	6.12e-05	0.000609	CcSEcCtD
Decitabine—Rash—Dactinomycin—skin cancer	6.07e-05	0.000604	CcSEcCtD
Decitabine—Myalgia—Docetaxel—skin cancer	6.04e-05	0.000601	CcSEcCtD
Decitabine—Chest pain—Docetaxel—skin cancer	6.04e-05	0.000601	CcSEcCtD
Decitabine—Arthralgia—Docetaxel—skin cancer	6.04e-05	0.000601	CcSEcCtD
Decitabine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	6e-05	0.000597	CcSEcCtD
Decitabine—Diarrhoea—Temozolomide—skin cancer	5.96e-05	0.000593	CcSEcCtD
Decitabine—Hypersensitivity—Fluorouracil—skin cancer	5.91e-05	0.000588	CcSEcCtD
Decitabine—Confusional state—Docetaxel—skin cancer	5.84e-05	0.000581	CcSEcCtD
Decitabine—Anaphylactic shock—Docetaxel—skin cancer	5.79e-05	0.000576	CcSEcCtD
Decitabine—Oedema—Docetaxel—skin cancer	5.79e-05	0.000576	CcSEcCtD
Decitabine—Dizziness—Temozolomide—skin cancer	5.76e-05	0.000573	CcSEcCtD
Decitabine—Infection—Docetaxel—skin cancer	5.75e-05	0.000573	CcSEcCtD
Decitabine—Nausea—Dactinomycin—skin cancer	5.72e-05	0.000569	CcSEcCtD
Decitabine—Nervous system disorder—Docetaxel—skin cancer	5.68e-05	0.000565	CcSEcCtD
Decitabine—Pruritus—Fluorouracil—skin cancer	5.68e-05	0.000565	CcSEcCtD
Decitabine—Thrombocytopenia—Docetaxel—skin cancer	5.67e-05	0.000564	CcSEcCtD
Decitabine—Tachycardia—Docetaxel—skin cancer	5.65e-05	0.000562	CcSEcCtD
Decitabine—Skin disorder—Docetaxel—skin cancer	5.63e-05	0.00056	CcSEcCtD
Decitabine—Vomiting—Temozolomide—skin cancer	5.54e-05	0.000551	CcSEcCtD
Decitabine—Anorexia—Docetaxel—skin cancer	5.52e-05	0.000549	CcSEcCtD
Decitabine—Rash—Temozolomide—skin cancer	5.49e-05	0.000546	CcSEcCtD
Decitabine—Diarrhoea—Fluorouracil—skin cancer	5.49e-05	0.000546	CcSEcCtD
Decitabine—Dermatitis—Temozolomide—skin cancer	5.49e-05	0.000546	CcSEcCtD
Decitabine—Headache—Temozolomide—skin cancer	5.46e-05	0.000543	CcSEcCtD
Decitabine—Hypotension—Docetaxel—skin cancer	5.41e-05	0.000539	CcSEcCtD
Decitabine—Dizziness—Fluorouracil—skin cancer	5.31e-05	0.000528	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Docetaxel—skin cancer	5.28e-05	0.000525	CcSEcCtD
Decitabine—Insomnia—Docetaxel—skin cancer	5.24e-05	0.000521	CcSEcCtD
Decitabine—Nausea—Temozolomide—skin cancer	5.17e-05	0.000515	CcSEcCtD
Decitabine—Dyspnoea—Docetaxel—skin cancer	5.16e-05	0.000514	CcSEcCtD
Decitabine—Vomiting—Fluorouracil—skin cancer	5.1e-05	0.000508	CcSEcCtD
Decitabine—Dyspepsia—Docetaxel—skin cancer	5.1e-05	0.000507	CcSEcCtD
Decitabine—Rash—Fluorouracil—skin cancer	5.06e-05	0.000503	CcSEcCtD
Decitabine—Dermatitis—Fluorouracil—skin cancer	5.06e-05	0.000503	CcSEcCtD
Decitabine—Decreased appetite—Docetaxel—skin cancer	5.04e-05	0.000501	CcSEcCtD
Decitabine—Headache—Fluorouracil—skin cancer	5.03e-05	0.0005	CcSEcCtD
Decitabine—Gastrointestinal disorder—Docetaxel—skin cancer	5e-05	0.000498	CcSEcCtD
Decitabine—Fatigue—Docetaxel—skin cancer	4.99e-05	0.000497	CcSEcCtD
Decitabine—Pain—Docetaxel—skin cancer	4.95e-05	0.000493	CcSEcCtD
Decitabine—Constipation—Docetaxel—skin cancer	4.95e-05	0.000493	CcSEcCtD
Decitabine—Feeling abnormal—Docetaxel—skin cancer	4.77e-05	0.000475	CcSEcCtD
Decitabine—Nausea—Fluorouracil—skin cancer	4.77e-05	0.000474	CcSEcCtD
Decitabine—Gastrointestinal pain—Docetaxel—skin cancer	4.74e-05	0.000471	CcSEcCtD
Decitabine—Body temperature increased—Docetaxel—skin cancer	4.58e-05	0.000456	CcSEcCtD
Decitabine—Abdominal pain—Docetaxel—skin cancer	4.58e-05	0.000456	CcSEcCtD
Decitabine—Hypersensitivity—Docetaxel—skin cancer	4.27e-05	0.000425	CcSEcCtD
Decitabine—Asthenia—Docetaxel—skin cancer	4.16e-05	0.000413	CcSEcCtD
Decitabine—Pruritus—Docetaxel—skin cancer	4.1e-05	0.000408	CcSEcCtD
Decitabine—Diarrhoea—Docetaxel—skin cancer	3.96e-05	0.000394	CcSEcCtD
Decitabine—Dizziness—Docetaxel—skin cancer	3.83e-05	0.000381	CcSEcCtD
Decitabine—Vomiting—Docetaxel—skin cancer	3.68e-05	0.000366	CcSEcCtD
Decitabine—Rash—Docetaxel—skin cancer	3.65e-05	0.000363	CcSEcCtD
Decitabine—Dermatitis—Docetaxel—skin cancer	3.65e-05	0.000363	CcSEcCtD
Decitabine—Headache—Docetaxel—skin cancer	3.63e-05	0.000361	CcSEcCtD
Decitabine—Nausea—Docetaxel—skin cancer	3.44e-05	0.000342	CcSEcCtD
